FDA Output, October 2025
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in October 2025. Updated October 27.
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in October 2025. Updated October 27.
An audio interview with the CEO of Madison Scientific about his entrepreneurial career, investment in medtech, and the drivers behind the companies he co-founded.
Medtronic and Edwards are expanding into the much smaller transcatheter pulmonary valve replacement market. Excerpted from our recent feature article “A Passion Project”: Edwards and Medtronic Persevere Against TPVR Challenges.”